Products

What will AGI do for Bretylium tosilate?

This classification denotes an antiarrhythmic agent with the molecular formula C11H17BrN.C7H7O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 78ZP3YR353, chemically known as 2-bromo-n-ethyl-n,n-dimethylbenzenemethanaminium 4-methylbenzenesulfonate but more generally known as bretylium tosilate, which bears US NIH Compound Identifier 6100. European Medicines Agency schedules Bretylium tosilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05887MIG. The term BRETYLIUM TOSYLATE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules bretylium tosilate in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations, for tariff and trade purposes, schedule bretylium tosilate under HS 29239000 and SITC 51481. SMILES: CC[N+](C)(C)CC1CCCCC1BR.CC1CCC(CC1)S(=O)(=O)[O-].